Browsing byAuthorWatson, WR
Showing results 1 to 1 of 1
Issue Date | Title | Author(s) |
2020-06-24 | The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe. | Drápela, S; Khirsariya, P; van Weerden, WM; Fedr, R; Suchánková, T; Búzová, D; Červený, J; Hampl, A; Puhr, M; Watson, WR; Culig, Z; Krejčí, L; Paruch, K; Souček, K |